This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Voronoi Inc.. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: The Innovative Contributions of Inventor Ju Hee Kang
Introduction: Ju Hee Kang, an accomplished inventor based in Incheon, South Korea, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Kang’s work primarily focuses on innovative compounds aimed at treating cancer. His latest inventions highlight his dedication to advancing medical research and treatment options.
Latest Patents: Kang's most recent patent involves the development of a heteroaryl derivative, specifically a 6-(isooxazolidin-2-yl)-N-phenylpyrimidin-4-amine derivative. This compound is not only innovative but also serves as a pharmaceutical composition designed for preventing or treating cancer. The patent explains that the compound exhibits high inhibitory activity against epidermal growth factor receptor (EGFR) variants, as well as wild-type or variants of ERBB2 and ERBB4. This remarkable inhibition suggests that the compound could be particularly useful in treating lung cancer, showing excellent activity against the proliferation of lung cancer cell lines.
Career Highlights: Ju Hee Kang works at Voronoi Inc., where he continues to focus on cutting-edge research in pharmaceuticals. His expertise and developments contribute substantially to the company's mission of enhancing cancer treatment options, thereby impacting patient lives positively.
Collaborations: At Voronoi Inc., Kang collaborates with notable colleagues, including Youn Ho Lee and Se In Kang. These partnerships are essential in fostering an environment of creativity and innovation, enabling significant advancements in their research pursuits.
Conclusion: Ju Hee Kang is a remarkable inventor who is making strides in the pharmaceutical field with his innovative compounds targeting cancer treatment. His latest patent demonstrates not only his technical expertise but also his commitment to improving healthcare outcomes. With ongoing research and collaboration, Kang continues to pave the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile